SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-130700
Filing Date
2023-05-01
Accepted
2023-05-01 17:14:07
Documents
6

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d492868dsc13da.htm SC 13D/A 31139
2 EX-1 d492868dex1.htm EX-1 40308
3 GRAPHIC g492868page010.jpg GRAPHIC 168735
4 GRAPHIC g492868page011.jpg GRAPHIC 173465
5 GRAPHIC g492868page012.jpg GRAPHIC 136205
6 GRAPHIC g492868page013.jpg GRAPHIC 70597
  Complete submission text file 0001193125-23-130700.txt   829537
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Subject) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90023 | Film No.: 23875023
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3000 WESTERN AVENUE SUITE 400 SEATTLE WA 98121
Business Address 3000 WESTERN AVENUE SUITE 400 SEATTLE WA 98121 425-220-2542
CBI USA, Inc. (Filed by) CIK: 0001930189 (see all company filings)

IRS No.: 863703094 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A